PAK1_HUMAN - dbPTM
PAK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PAK1_HUMAN
UniProt AC Q13153
Protein Name Serine/threonine-protein kinase PAK 1 {ECO:0000303|PubMed:8805275}
Gene Name PAK1 {ECO:0000312|HGNC:HGNC:8590}
Organism Homo sapiens (Human).
Sequence Length 545
Subcellular Localization Cytoplasm . Cell junction, focal adhesion . Cell membrane . Cell projection, ruffle membrane . Cell projection, invadopodium . Colocalizes with RUFY3, F-actin and other core migration components in invadopodia at the cell periphery (PubMed:25766321).
Protein Description Protein kinase involved in intracellular signaling pathways downstream of integrins and receptor-type kinases that plays an important role in cytoskeleton dynamics, in cell adhesion, migration, proliferation, apoptosis, mitosis, and in vesicle-mediated transport processes. Can directly phosphorylate BAD and protects cells against apoptosis. Activated by interaction with CDC42 and RAC1. Functions as GTPase effector that links the Rho-related GTPases CDC42 and RAC1 to the JNK MAP kinase pathway. Phosphorylates and activates MAP2K1, and thereby mediates activation of downstream MAP kinases. Involved in the reorganization of the actin cytoskeleton, actin stress fibers and of focal adhesion complexes. Phosphorylates the tubulin chaperone TBCB and thereby plays a role in the regulation of microtubule biogenesis and organization of the tubulin cytoskeleton. Plays a role in the regulation of insulin secretion in response to elevated glucose levels. Part of a ternary complex that contains PAK1, DVL1 and MUSK that is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2. Phosphorylates MYL9/MLC2. Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2. Phosphorylates SNAI1 at 'Ser-246' promoting its transcriptional repressor activity by increasing its accumulation in the nucleus. In podocytes, promotes NR3C2 nuclear localization. Required for atypical chemokine receptor ACKR2-induced phosphorylation of LIMK1 and cofilin (CFL1) and for the up-regulation of ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. In synapses, seems to mediate the regulation of F-actin cluster formation performed by SHANK3, maybe through CFL1 phosphorylation and inactivation. Plays a role in RUFY3-mediated facilitating gastric cancer cells migration and invasion. [PubMed: 25766321]
Protein Sequence MSNNGLDIQDKPPAPPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILPGDKTNKKKEKERPEISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKNPQAVLDVLEFYNSKKTSNSQKYMSFTDKSAEDYNSSNALNVKAVSETPAVPPVSEDEDDDDDDATPPPVIAPRPEHTKSVYTRSVIEPLPVTPTRDVATSPISPTENNTTPPDALTRNTEKQKKKPKMSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSNNGLDIQ
------CCCCCCCCC
38.7222814378
2Phosphorylation------MSNNGLDIQ
------CCCCCCCCC
38.7227050516
2 (in isoform 2)Phosphorylation-38.7224719451
11UbiquitinationNGLDIQDKPPAPPMR
CCCCCCCCCCCCCCC
36.20-
20PhosphorylationPAPPMRNTSTMIGAG
CCCCCCCCCCCCCCC
18.4021406692
20 (in isoform 2)Phosphorylation-18.4027251275
21PhosphorylationAPPMRNTSTMIGAGS
CCCCCCCCCCCCCCC
21.3721406692
22PhosphorylationPPMRNTSTMIGAGSK
CCCCCCCCCCCCCCC
15.6921406692
28PhosphorylationSTMIGAGSKDAGTLN
CCCCCCCCCCCCCCC
27.1621406692
28 (in isoform 2)Phosphorylation-27.1627251275
29AcetylationTMIGAGSKDAGTLNH
CCCCCCCCCCCCCCC
51.1623954790
29UbiquitinationTMIGAGSKDAGTLNH
CCCCCCCCCCCCCCC
51.16-
38PhosphorylationAGTLNHGSKPLPPNP
CCCCCCCCCCCCCCH
24.4524719451
39UbiquitinationGTLNHGSKPLPPNPE
CCCCCCCCCCCCCHH
55.98-
57PhosphorylationKKDRFYRSILPGDKT
HHHHHHHHHCCCCCC
19.669032240
63AcetylationRSILPGDKTNKKKEK
HHHCCCCCCCCCCCC
60.9723749302
76PhosphorylationEKERPEISLPSDFEH
CCCCCCCCCCCCCCC
32.3427732954
79PhosphorylationRPEISLPSDFEHTIH
CCCCCCCCCCCCEEE
61.2927732954
84PhosphorylationLPSDFEHTIHVGFDA
CCCCCCCEEEEEEEC
12.9414707132
109PhosphorylationQWARLLQTSNITKSE
HHHHHHHHCCCCHHH
24.5830266825
110PhosphorylationWARLLQTSNITKSEQ
HHHHHHHCCCCHHHH
17.1830266825
113PhosphorylationLLQTSNITKSEQKKN
HHHHCCCCHHHHHCC
32.5430266825
115PhosphorylationQTSNITKSEQKKNPQ
HHCCCCHHHHHCCHH
36.2930266825
115 (in isoform 2)Phosphorylation-36.2924719451
131PhosphorylationVLDVLEFYNSKKTSN
HHHHHHHHHCCCCCC
14.7829978859
131 (in isoform 2)Phosphorylation-14.7827642862
133PhosphorylationDVLEFYNSKKTSNSQ
HHHHHHHCCCCCCCC
24.9329978859
136PhosphorylationEFYNSKKTSNSQKYM
HHHHCCCCCCCCCCC
36.5630108239
136 (in isoform 2)Phosphorylation-36.5627642862
137PhosphorylationFYNSKKTSNSQKYMS
HHHCCCCCCCCCCCC
43.2830108239
139PhosphorylationNSKKTSNSQKYMSFT
HCCCCCCCCCCCCCC
28.0230108239
139 (in isoform 2)Phosphorylation-28.0224719451
142PhosphorylationKTSNSQKYMSFTDKS
CCCCCCCCCCCCCCC
7.1429255136
142 (in isoform 2)Phosphorylation-7.1427642862
144PhosphorylationSNSQKYMSFTDKSAE
CCCCCCCCCCCCCHH
23.1619664994
144 (in isoform 2)Phosphorylation-23.1624719451
146PhosphorylationSQKYMSFTDKSAEDY
CCCCCCCCCCCHHHH
34.9030266825
148UbiquitinationKYMSFTDKSAEDYNS
CCCCCCCCCHHHHCC
48.81-
149PhosphorylationYMSFTDKSAEDYNSS
CCCCCCCCHHHHCCC
39.4321945579
149 (in isoform 2)Phosphorylation-39.4327251275
153PhosphorylationTDKSAEDYNSSNALN
CCCCHHHHCCCCCCC
14.4021945579
153 (in isoform 2)Phosphorylation-14.4027642862
155PhosphorylationKSAEDYNSSNALNVK
CCHHHHCCCCCCCCE
20.8121945579
155 (in isoform 2)Phosphorylation-20.8127251275
156PhosphorylationSAEDYNSSNALNVKA
CHHHHCCCCCCCCEE
23.6021945579
156 (in isoform 2)Phosphorylation-23.6024719451
165PhosphorylationALNVKAVSETPAVPP
CCCCEEEECCCCCCC
40.3829255136
167PhosphorylationNVKAVSETPAVPPVS
CCEEEECCCCCCCCC
14.7229255136
174PhosphorylationTPAVPPVSEDEDDDD
CCCCCCCCCCCCCCC
45.1429255136
174 (in isoform 2)Phosphorylation-45.1427251275
185PhosphorylationDDDDDDATPPPVIAP
CCCCCCCCCCCEECC
43.2429255136
185 (in isoform 2)Phosphorylation-43.2427251275
197PhosphorylationIAPRPEHTKSVYTRS
ECCCCCCCCCCCCCC
24.2930278072
199PhosphorylationPRPEHTKSVYTRSVI
CCCCCCCCCCCCCEE
22.8521278788
201PhosphorylationPEHTKSVYTRSVIEP
CCCCCCCCCCCEEEC
11.9717726028
202PhosphorylationEHTKSVYTRSVIEPL
CCCCCCCCCCEEECC
17.8228634298
204PhosphorylationTKSVYTRSVIEPLPV
CCCCCCCCEEECCCC
21.4619664994
204 (in isoform 2)Phosphorylation-21.4624719451
212PhosphorylationVIEPLPVTPTRDVAT
EEECCCCCCCCCCCC
19.5919664994
212 (in isoform 2)Phosphorylation-19.5924719451
214PhosphorylationEPLPVTPTRDVATSP
ECCCCCCCCCCCCCC
30.0929255136
214 (in isoform 2)Phosphorylation-30.0924719451
219PhosphorylationTPTRDVATSPISPTE
CCCCCCCCCCCCCCC
34.5830266825
219 (in isoform 2)Phosphorylation-34.5827251275
220PhosphorylationPTRDVATSPISPTEN
CCCCCCCCCCCCCCC
15.5330266825
220 (in isoform 2)Phosphorylation-15.5324719451
223PhosphorylationDVATSPISPTENNTT
CCCCCCCCCCCCCCC
29.2029255136
223 (in isoform 2)Phosphorylation-29.2024719451
225PhosphorylationATSPISPTENNTTPP
CCCCCCCCCCCCCCC
44.5529255136
225 (in isoform 2)Phosphorylation-44.5524719451
229PhosphorylationISPTENNTTPPDALT
CCCCCCCCCCCCHHC
52.8729255136
230PhosphorylationSPTENNTTPPDALTR
CCCCCCCCCCCHHCC
34.6429255136
230 (in isoform 2)Phosphorylation-34.6424719451
236PhosphorylationTTPPDALTRNTEKQK
CCCCCHHCCCCHHHH
24.4830266825
239PhosphorylationPDALTRNTEKQKKKP
CCHHCCCCHHHHCCC
41.0726074081
245AcetylationNTEKQKKKPKMSDEE
CCHHHHCCCCCCHHH
57.8319413330
248SulfoxidationKQKKKPKMSDEEILE
HHHCCCCCCHHHHHH
9.1721406390
249PhosphorylationQKKKPKMSDEEILEK
HHCCCCCCHHHHHHH
48.2526074081
256SumoylationSDEEILEKLRSIVSV
CHHHHHHHHHHHHCC
45.84-
256AcetylationSDEEILEKLRSIVSV
CHHHHHHHHHHHHCC
45.8419608861
256SumoylationSDEEILEKLRSIVSV
CHHHHHHHHHHHHCC
45.84-
256UbiquitinationSDEEILEKLRSIVSV
CHHHHHHHHHHHHCC
45.84-
259PhosphorylationEILEKLRSIVSVGDP
HHHHHHHHHHCCCCC
37.4728348404
262PhosphorylationEKLRSIVSVGDPKKK
HHHHHHHCCCCCCCC
20.79-
271PhosphorylationGDPKKKYTRFEKIGQ
CCCCCCEECCEECCC
37.4529496963
281PhosphorylationEKIGQGASGTVYTAM
EECCCCCCCCEEEEE
41.6522210691
285PhosphorylationQGASGTVYTAMDVAT
CCCCCCEEEEEECCC
6.6617726028
299UbiquitinationTGQEVAIKQMNLQQQ
CCCCHHHHHCCCCCC
33.48-
309UbiquitinationNLQQQPKKELIINEI
CCCCCCCHHHEEEEH
65.52-
391UbiquitinationQVIHRDIKSDNILLG
CCEECCCCCCCEEEC
56.92-
415PhosphorylationFGFCAQITPEQSKRS
CCEEEECCHHHHCCC
14.5325159151
419PhosphorylationAQITPEQSKRSTMVG
EECCHHHHCCCCCCC
28.5128787133
420AcetylationQITPEQSKRSTMVGT
ECCHHHHCCCCCCCC
50.4924179719
420UbiquitinationQITPEQSKRSTMVGT
ECCHHHHCCCCCCCC
50.492190698
420 (in isoform 1)Ubiquitination-50.4921906983
420 (in isoform 2)Ubiquitination-50.4921906983
422PhosphorylationTPEQSKRSTMVGTPY
CHHHHCCCCCCCCCC
25.2927461979
423PhosphorylationPEQSKRSTMVGTPYW
HHHHCCCCCCCCCCC
21.6522153498
427PhosphorylationKRSTMVGTPYWMAPE
CCCCCCCCCCCCCCH
11.2023401153
429PhosphorylationSTMVGTPYWMAPEVV
CCCCCCCCCCCCHHH
13.9823401153
437PhosphorylationWMAPEVVTRKAYGPK
CCCCHHHCCCCCCCC
31.4623401153
474PhosphorylationENPLRALYLIATNGT
CCHHHHHHHHHCCCC
8.6228152594
478PhosphorylationRALYLIATNGTPELQ
HHHHHHHCCCCHHHC
27.4728152594
481PhosphorylationYLIATNGTPELQNPE
HHHHCCCCHHHCCHH
18.6922817901
491PhosphorylationLQNPEKLSAIFRDFL
HCCHHHHHHHHHHHH
30.31-
508UbiquitinationCLEMDVEKRGSAKEL
HHHCCHHHCCCHHHH
63.00-
511PhosphorylationMDVEKRGSAKELLQH
CCHHHCCCHHHHHHH
39.9524719451
513AcetylationVEKRGSAKELLQHQF
HHHCCCHHHHHHHHH
51.0611921281
528PhosphorylationLKIAKPLSSLTPLIA
HHHHHCHHHHHHHHH
31.65-
529PhosphorylationKIAKPLSSLTPLIAA
HHHHCHHHHHHHHHH
43.90-
531PhosphorylationAKPLSSLTPLIAAAK
HHCHHHHHHHHHHHH
20.28-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
21SPhosphorylationKinasePKBP31749
Uniprot
21SPhosphorylationKinaseAKT-FAMILY-GPS
21SPhosphorylationKinasePRKG1Q13976-2
GPS
57SPhosphorylationKinasePAK1Q13153
GPS
84TPhosphorylationKinaseOXSR1O95747
Uniprot
109TPhosphorylationKinaseLKB1Q9WTK7
PSP
109TPhosphorylationKinaseSTK11Q15831
GPS
133SPhosphorylationKinaseMLK3Q16584
PSP
144SPhosphorylationKinasePAK1Q13153
PSP
153YPhosphorylationKinaseBMXP51813
GPS
153YPhosphorylationKinaseJAK2O60674
Uniprot
174SPhosphorylationKinaseCDK19Q9BWU1
PSP
199SPhosphorylationKinasePAK1Q13153
PSP
201YPhosphorylationKinaseJAK2O60674
Uniprot
204SPhosphorylationKinaseMLK3Q16584
PSP
204SPhosphorylationKinasePAK1Q13153
PSP
212TPhosphorylationKinaseMAPK1P28482
GPS
212TPhosphorylationKinaseCDK-FAMILY-GPS
212TPhosphorylationKinaseCDK_GROUP-PhosphoELM
223SPhosphorylationKinaseCSNK2A1P68400
GPS
285YPhosphorylationKinaseJAK2O60674
Uniprot
423TPhosphorylationKinasePAK1Q13153
PSP
423TPhosphorylationKinasePDK1Q15118
GPS
423TPhosphorylationKinasePDK1O15530
PSP
423TPhosphorylationKinaseBRSK2Q8IWQ3
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
21SPhosphorylation

14585966
212TPhosphorylation

16964243
423TPhosphorylation

10551809
423TPhosphorylation

10551809

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PAK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ARHG2_HUMANARHGEF2physical
14970201
ARC1B_HUMANARPC1Bphysical
14749719
RAC1_HUMANRAC1physical
12879077
RAC1_HUMANRAC1physical
12650940
CDC42_HUMANCDC42physical
12650940
CD11A_HUMANCDK11Aphysical
12624090
ERBB2_HUMANERBB2physical
9774445
DYL1_HUMANDYNLL1physical
15193260
PK1IP_HUMANPAK1IP1physical
11371639
LIMK1_HUMANLIMK1physical
10559936
RAF1_HUMANRAF1physical
11733498
HGS_HUMANHGSphysical
11397816
ARHG7_HUMANARHGEF7physical
11157752
MYLK_HUMANMYLKphysical
10092231
NCK1_HUMANNCK1physical
8824201
BMX_HUMANBMXphysical
11382770
PAK1_HUMANPAK1physical
11804587
PAK1_HUMANPAK1physical
10975528
SH3K1_HUMANSH3KBP1physical
16407834
HS90A_HUMANHSP90AA1physical
20936779
1433G_HUMANYWHAGphysical
20936779
1433Z_HUMANYWHAZphysical
20936779
ARHG7_HUMANARHGEF7physical
20936779
DYR1B_HUMANDYRK1Bphysical
20936779
ZBT18_HUMANZBTB18physical
20936779
Z3H7A_HUMANZC3H7Aphysical
20936779
ZN823_HUMANZNF823physical
20936779
ZNF83_HUMANZNF83physical
20936779
MYNN_HUMANMYNNphysical
20936779
CE042_HUMANC5orf42physical
20936779
ZN418_HUMANZNF418physical
20936779
RAC1_HUMANRAC1physical
21474670
RAC1_HUMANRAC1physical
15673687
RAC1_HUMANRAC1physical
19327867
RAC1_HUMANRAC1physical
16002993
NCK1_HUMANNCK1physical
10372803
RAC1_HUMANRAC1physical
16551621
ELF3_HUMANELF3physical
17491012
GBB1_HUMANGNB1physical
12887923
M3K1_HUMANMAP3K1physical
12228228
CDC42_HUMANCDC42physical
16678097
RAC1_HUMANRAC1physical
16678097
RAC1_HUMANRAC1physical
15075243
MYO6_HUMANMYO6physical
9852149
NCK2_HUMANNCK2physical
11557983
NCK1_HUMANNCK1physical
11557983
TGFR1_HUMANTGFBR1physical
15761153
TGFR2_HUMANTGFBR2physical
15761153
A4_HUMANAPPphysical
21832049
CRPAK_HUMANCRIPAKphysical
16278681
PAK1_HUMANPAK1physical
16278681
CHRD1_HUMANCHORDC1physical
19910486
ESR1_HUMANESR1physical
16452229
BAD_HUMANBADphysical
15849194
CDC42_YEASTCDC42physical
20171953
H31_HUMANHIST1H3Aphysical
12151336
ESR1_HUMANESR1physical
12374744
BAD_HUMANBADphysical
19667065
NCK2_HUMANNCK2physical
23455922
CDC42_HUMANCDC42physical
23455922
PAK2_HUMANPAK2physical
23455922
ARHG7_HUMANARHGEF7physical
23455922
ARHG6_HUMANARHGEF6physical
23455922
FBX28_HUMANFBXO28physical
23455922
GIT1_HUMANGIT1physical
23455922
VINEX_HUMANSORBS3physical
15784622
BAD_HUMANBADphysical
15784622
NCK2_HUMANNCK2physical
25416956
AKT1_HUMANAKT1physical
24886428
BRSK1_HUMANBRSK1physical
22669945
RAC1_HUMANRAC1physical
19961560
GIT1_HUMANGIT1physical
25852190
GIT2_HUMANGIT2physical
25852190
H2AX_HUMANH2AFXphysical
25852190
CDC42_HUMANCDC42physical
18057010
RAC1_HUMANRAC1physical
11130076
TF65_HUMANRELAphysical
26036343
RHOU_HUMANRHOUphysical
26598620
RAC1_HUMANRAC1physical
19277120
RAC1_HUMANRAC1physical
25468898
PAK1_HUMANPAK1physical
18586681
RAC1_HUMANRAC1physical
15548653
CDC42_HUMANCDC42physical
15548653
RAC1_HUMANRAC1physical
15212766
RAC1_CAEELced-10physical
15700267
RAC1_HUMANRAC1physical
25819133
BAD_HUMANBADphysical
10611223
BAD_MOUSEBadphysical
10611223
RAC1_HUMANRAC1physical
15143066

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PAK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-256, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-144; SER-204; THR-212;THR-219; SER-220 AND THR-230, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-212; THR-225; THR-229AND THR-230, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-230, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-212, AND MASSSPECTROMETRY.
"p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1).";
King C.C., Gardiner E.M., Zenke F.T., Bohl B.P., Newton A.C.,Hemmings B.A., Bokoch G.M.;
J. Biol. Chem. 275:41201-41209(2000).
Cited for: PHOSPHORYLATION AT THR-423 BY PDPK1, INTERACTION WITH PDPK1, ANDENZYME REGULATION.
"Identification of a central phosphorylation site in p21-activatedkinase regulating autoinhibition and kinase activity.";
Zenke F.T., King C.C., Bohl B.P., Bokoch G.M.;
J. Biol. Chem. 274:32565-32573(1999).
Cited for: PHOSPHORYLATION AT THR-423, AND MUTAGENESIS OF THR-423.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-474, AND MASSSPECTROMETRY.

TOP